Armata Pharmaceuticals Inc (ARMP)
2.40
-0.15
(-5.88%)
USD |
NYAM |
May 01, 16:00
Armata Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | -11.76K% |
| September 30, 2017 | -2.05K% |
| June 30, 2017 | -23.08K% |
| March 31, 2017 | -11.19K% |
| December 31, 2016 | -43.18K% |
| September 30, 2016 | -8.19K% |
| June 30, 2016 | -3.74K% |
| March 31, 2016 | -2.94K% |
| December 31, 2015 | -1.74K% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -14.21K% |
| December 31, 2014 | -657.4% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | -10.87K% |
| December 31, 2013 | -181.7% |
| September 30, 2013 | |
| June 30, 2013 | -4.66K% |
| March 31, 2013 | -7.48K% |
| September 30, 2009 | 18.08% |
| June 30, 2009 | |
| March 31, 2009 | -88.27% |
| December 31, 2008 | -484.3% |
| September 30, 2008 | -152.8% |
| Date | Value |
|---|---|
| June 30, 2008 | -169.7% |
| March 31, 2008 | -136.6% |
| December 31, 2007 | -157.5% |
| September 30, 2007 | -124.1% |
| June 30, 2007 | -139.2% |
| March 31, 2007 | -230.9% |
| December 31, 2006 | 20.16% |
| September 30, 2006 | -158.5% |
| June 30, 2006 | -1.97K% |
| March 31, 2006 | -153.6% |
| December 31, 2005 | -182.6% |
| September 30, 2005 | -387.1% |
| June 30, 2005 | -362.1% |
| March 31, 2005 | -233.6% |
| December 31, 2004 | -69.90% |
| September 30, 2004 | -114.1% |
| June 30, 2004 | -161.2% |
| March 31, 2004 | -368.0% |
| December 31, 2003 | -457.4% |
| September 30, 2003 | -15.59% |
| June 30, 2003 | -336.8% |
| March 31, 2003 | -14.72% |
| December 31, 2002 | -133.9% |
| September 30, 2002 | -100.2% |
| June 30, 2002 | -140.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 12.23% |
| Xtant Medical Holdings Inc | -15.31% |